CA2277366A1 - Transdermal, acetylsalicylic acid-containing therapeutic system with reinforced resorption - Google Patents
Transdermal, acetylsalicylic acid-containing therapeutic system with reinforced resorption Download PDFInfo
- Publication number
- CA2277366A1 CA2277366A1 CA002277366A CA2277366A CA2277366A1 CA 2277366 A1 CA2277366 A1 CA 2277366A1 CA 002277366 A CA002277366 A CA 002277366A CA 2277366 A CA2277366 A CA 2277366A CA 2277366 A1 CA2277366 A1 CA 2277366A1
- Authority
- CA
- Canada
- Prior art keywords
- limonene
- acetylsalicylic acid
- therapeutic system
- dimethylisosorbide
- transdermal therapeutic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- BSYNRYMUTXBXSQ-UHFFFAOYSA-N Aspirin Chemical compound CC(=O)OC1=CC=CC=C1C(O)=O BSYNRYMUTXBXSQ-UHFFFAOYSA-N 0.000 title claims abstract description 27
- 229960001138 acetylsalicylic acid Drugs 0.000 title claims abstract description 27
- 230000001225 therapeutic effect Effects 0.000 title claims abstract description 20
- XMGQYMWWDOXHJM-UHFFFAOYSA-N limonene Chemical compound CC(=C)C1CCC(C)=CC1 XMGQYMWWDOXHJM-UHFFFAOYSA-N 0.000 claims abstract description 44
- 229940087305 limonene Drugs 0.000 claims abstract description 22
- 235000001510 limonene Nutrition 0.000 claims abstract description 22
- MEJYDZQQVZJMPP-ULAWRXDQSA-N (3s,3ar,6r,6ar)-3,6-dimethoxy-2,3,3a,5,6,6a-hexahydrofuro[3,2-b]furan Chemical compound CO[C@H]1CO[C@@H]2[C@H](OC)CO[C@@H]21 MEJYDZQQVZJMPP-ULAWRXDQSA-N 0.000 claims abstract description 20
- 238000002156 mixing Methods 0.000 claims abstract description 8
- 239000010410 layer Substances 0.000 claims description 16
- 239000004480 active ingredient Substances 0.000 claims description 7
- 239000011159 matrix material Substances 0.000 claims description 7
- BSYNRYMUTXBXSQ-FOQJRBATSA-N 59096-14-9 Chemical compound CC(=O)OC1=CC=CC=C1[14C](O)=O BSYNRYMUTXBXSQ-FOQJRBATSA-N 0.000 claims description 4
- 229920000642 polymer Polymers 0.000 claims description 4
- 239000011241 protective layer Substances 0.000 claims description 2
- 239000002356 single layer Substances 0.000 claims 1
- 239000013543 active substance Substances 0.000 abstract description 3
- 239000004744 fabric Substances 0.000 description 13
- 229920000728 polyester Polymers 0.000 description 8
- 239000000203 mixture Substances 0.000 description 7
- 239000000853 adhesive Substances 0.000 description 6
- 230000001070 adhesive effect Effects 0.000 description 6
- 229920001577 copolymer Polymers 0.000 description 5
- 229920000742 Cotton Polymers 0.000 description 4
- WFDIJRYMOXRFFG-UHFFFAOYSA-N acetic acid anhydride Natural products CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 239000000654 additive Substances 0.000 description 3
- 238000001035 drying Methods 0.000 description 3
- 238000001914 filtration Methods 0.000 description 3
- 229920006395 saturated elastomer Polymers 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 2
- PPBRXRYQALVLMV-UHFFFAOYSA-N Styrene Chemical compound C=CC1=CC=CC=C1 PPBRXRYQALVLMV-UHFFFAOYSA-N 0.000 description 2
- 238000006460 hydrolysis reaction Methods 0.000 description 2
- 229940070721 polyacrylate Drugs 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 238000005809 transesterification reaction Methods 0.000 description 2
- 101000783577 Dendroaspis angusticeps Thrombostatin Proteins 0.000 description 1
- 101000783578 Dendroaspis jamesoni kaimosae Dendroaspin Proteins 0.000 description 1
- 229920002367 Polyisobutene Polymers 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 230000001754 anti-pyretic effect Effects 0.000 description 1
- 229940127218 antiplatelet drug Drugs 0.000 description 1
- 239000002221 antipyretic Substances 0.000 description 1
- 239000003435 antirheumatic agent Substances 0.000 description 1
- 150000001733 carboxylic acid esters Chemical class 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 125000004185 ester group Chemical group 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 239000012907 medicinal substance Substances 0.000 description 1
- 239000000155 melt Substances 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 239000012466 permeate Substances 0.000 description 1
- 239000000106 platelet aggregation inhibitor Substances 0.000 description 1
- 229920000058 polyacrylate Polymers 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005573 silicon-containing polymer Polymers 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 231100001274 therapeutic index Toxicity 0.000 description 1
- 229920001169 thermoplastic Polymers 0.000 description 1
- 229920005992 thermoplastic resin Polymers 0.000 description 1
- 239000004416 thermosoftening plastic Substances 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
- A61K31/612—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid
- A61K31/616—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid by carboxylic acids, e.g. acetylsalicylic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
- A61K9/7061—Polyacrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7092—Transdermal patches having multiple drug layers or reservoirs, e.g. for obtaining a specific release pattern, or for combining different drugs
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19701059.8 | 1997-01-15 | ||
DE19701059A DE19701059C2 (de) | 1997-01-15 | 1997-01-15 | Acetylsalicylsäure enthaltendes transdermales therapeutisches System mit Resorptionsverstärkung |
PCT/EP1998/000013 WO1998031348A1 (de) | 1997-01-15 | 1998-01-03 | Acetylsalicylsäure enthaltendes transdermales therapeutisches system mit resorptionsverstärkung |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2277366A1 true CA2277366A1 (en) | 1998-07-23 |
Family
ID=7817375
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002277366A Abandoned CA2277366A1 (en) | 1997-01-15 | 1998-01-03 | Transdermal, acetylsalicylic acid-containing therapeutic system with reinforced resorption |
Country Status (8)
Country | Link |
---|---|
EP (1) | EP1023053A1 (no) |
JP (1) | JP2001508069A (no) |
KR (1) | KR20000070228A (no) |
AU (1) | AU726094B2 (no) |
CA (1) | CA2277366A1 (no) |
DE (1) | DE19701059C2 (no) |
NO (1) | NO993435D0 (no) |
WO (1) | WO1998031348A1 (no) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19949252B4 (de) * | 1999-10-13 | 2004-02-12 | Lts Lohmann Therapie-Systeme Ag | Verwendung eines superfiziellen therapeutischen Systems zur topischen Applikation von Acetylsalicylsäure zur Behandlung von Akne-Erkrankungen und Verfahren zu seiner Herstellung |
DE19949202A1 (de) * | 1999-10-13 | 2001-05-03 | Lohmann Therapie Syst Lts | Transdermales therapeutisches System zur Abgabe von Acetylsalicylsäure und/oder Salicylsäure |
DE19959913A1 (de) * | 1999-12-11 | 2001-06-28 | Lohmann Therapie Syst Lts | Acetylsalicylsäure enthaltendes transdermales System zur Behandlung von Migräne |
KR100448469B1 (ko) * | 2001-10-26 | 2004-09-13 | 신풍제약주식회사 | 항염증제의 경피 조성물 및 장치 |
JP4837892B2 (ja) | 2001-11-01 | 2011-12-14 | ネクター セラピューティクス | 粉末バッチを製造する方法 |
DE10338162B3 (de) † | 2003-08-20 | 2005-06-02 | Haldex Brake Products Gmbh | Verfahren zum Betreiben einer Druckluftbeschaffungsanlage eines Kraftfahrzeuges sowie Druckluftaufbereitungseinrichtung |
DE102005033543A1 (de) * | 2005-07-14 | 2007-01-18 | Grünenthal GmbH | Ein einen Duftstoff aufweisendes transdermales therapeutisches System |
DE102005050431A1 (de) * | 2005-10-21 | 2007-04-26 | Lts Lohmann Therapie-Systeme Ag | Transdermales therapeutisches System zur Verabreicherung lipophiler und/oder wenig hautpermeabler Wirkstoffe |
IT202000014578A1 (it) * | 2020-06-18 | 2021-12-18 | Poli Md S R L | Dispositivo medicale comprendente acido acetil salicilico |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4228162A (en) * | 1979-07-09 | 1980-10-14 | Research Corporation | Dimethyl isosorbide in liquid formulation of aspirin |
US5164416A (en) * | 1989-02-03 | 1992-11-17 | Lintec Corporation | Transdermal therapeutic formulation containing a limonene |
DE4332094C2 (de) * | 1993-09-22 | 1995-09-07 | Lohmann Therapie Syst Lts | Lösemittelfrei herstellbares Wirkstoffpflaster und Verfahren zu seiner Herstellung |
DE4332093C2 (de) * | 1993-09-22 | 1995-07-13 | Lohmann Therapie Syst Lts | Transdermales therapeutisches System mit dem Wirkstoff Acetylsalicylsäure und Verfahren zu seiner Herstellung |
-
1997
- 1997-01-15 DE DE19701059A patent/DE19701059C2/de not_active Expired - Fee Related
-
1998
- 1998-01-03 WO PCT/EP1998/000013 patent/WO1998031348A1/de not_active Application Discontinuation
- 1998-01-03 JP JP53137698A patent/JP2001508069A/ja active Pending
- 1998-01-03 KR KR1019997006454A patent/KR20000070228A/ko not_active Application Discontinuation
- 1998-01-03 AU AU59862/98A patent/AU726094B2/en not_active Ceased
- 1998-01-03 EP EP98902976A patent/EP1023053A1/de not_active Withdrawn
- 1998-01-03 CA CA002277366A patent/CA2277366A1/en not_active Abandoned
-
1999
- 1999-07-12 NO NO993435A patent/NO993435D0/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
EP1023053A1 (de) | 2000-08-02 |
AU5986298A (en) | 1998-08-07 |
AU726094B2 (en) | 2000-11-02 |
DE19701059A1 (de) | 1998-07-16 |
JP2001508069A (ja) | 2001-06-19 |
KR20000070228A (ko) | 2000-11-25 |
WO1998031348A1 (de) | 1998-07-23 |
DE19701059C2 (de) | 2000-12-21 |
NO993435L (no) | 1999-07-12 |
NO993435D0 (no) | 1999-07-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RU2212232C2 (ru) | Пластырь местного действия с нестероидными антиревматическими средствами, содержащими кислотную группу | |
DE4020144C2 (no) | ||
CA2125662C (en) | Transdermally administered system containing acetylsalicylic acid for thrombosis therapy and cancer prophylaxis | |
JP2000517343A (ja) | 医薬の塩を経皮送達するための感圧接着剤マトリックスパッチ | |
US5518734A (en) | Transdermal delivery system for estradiol and process for manufacturing said device | |
JP2638635B2 (ja) | 経皮吸収製剤 | |
CA2200189C (en) | Scopolamine plaster | |
JPS6049601B2 (ja) | 治療デバイス | |
AU726094B2 (en) | Acetylsalicylic acid-containing transdermal therapeutic system with absorption enhancement | |
CA2552679C (en) | Tulobuterol adhesive patch | |
JP2869167B2 (ja) | 徐放性貼付製剤 | |
US5705185A (en) | Transdermal delivery of estradiol and process for manufacturing said device | |
JP4943643B2 (ja) | 経皮吸収製剤 | |
JPS63307818A (ja) | 経皮吸収貼付剤 | |
JPS5835112A (ja) | 複合製剤 | |
SK22097A3 (en) | Transdermal therapeutic system and a method for producing same | |
MXPA99006584A (es) | Sistema terapeutico percutaneo que contiene acidoacetilsalicilico con refuerzo de resorcion | |
JPS5835113A (ja) | 複合製剤 | |
JPH0999050A (ja) | 貼付剤 | |
JPH0474119A (ja) | 貼付製剤 | |
JPH1179980A (ja) | 経皮吸収型製剤 | |
JP3229171B2 (ja) | 貼付剤 | |
AU2007202273B2 (en) | Transdermal therapeutic system containing fentanyl or related substance | |
JPH0853347A (ja) | 経皮吸収製剤 | |
JPS60184010A (ja) | 経皮投与用医薬製剤 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request | ||
FZDE | Discontinued | ||
FZDE | Discontinued |
Effective date: 20030103 |